Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kendall Keith J
CEO and President at Aquestive Therapeutics. Filing since 21 Nov 2018.
CIK 0001406834
Company
Date
Role
Action
Shares
Amount
Of holding
AQST
Aquestive Therapeutics, Inc.
4 Jun 2020
CEO and President
Sold, plan not stated
50,000
$255.31K
7.3%
AQST
Aquestive Therapeutics, Inc.
14 Aug 2019
CEO and President
Bought
2,000
$7.35K
0.3%
AQST
Aquestive Therapeutics, Inc.
13 Aug 2019
CEO and President
Bought
1,000
$4.05K
0.2%
AQST
Aquestive Therapeutics, Inc.
9 Aug 2019
CEO and President
Bought
5,000
$19.60K
0.8%
AQST
Aquestive Therapeutics, Inc.
27 Nov 2018
CEO and President
Bought
1,000
$9.87K
0.2%
AQST
Aquestive Therapeutics, Inc.
23 Nov 2018
CEO and President
Bought
1,950
$19.31K
0.3%
AQST
Aquestive Therapeutics, Inc.
21 Nov 2018
CEO and President
Bought
6,000
$61.02K
1.0%
7 decisions on file.
